Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study
Lupus · 2023
DOI: 10.1177/09612033231164091 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Lupus, 2023. Verfasst von Edward Itelman und 7 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine "T", Chaim Sheba Medical Center, Tel Hashomer, Israel. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Antiphospholipid Syndrome, Venous Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Purpose
To investigate whether low complement levels can predict worse outcomes in patients hospitalized with positive anti-phospholipid antibodies.
Methods
This was a retrospective cohort study. We obtained demographics, laboratory, and prognostic data of all consecutive patients hospitalized between 2007 and 2021, for whatever reason, with at least one positively abnormal anti-phospholipid antibody, who were also tested for complement levels (C3 or C4). We then compared the rates of long-term mortality, 1-year mortality, deep vein thrombosis, and pulmonary emboli between groups of low complement and normal complement levels. Multivariate analysis was used to control for levels of clinical and laboratory confounders.
Results
We identified 32,286 patients tested for anti-phospholipid antibodies. Of those patients, 6800 tested positive for at least one anti-phospholipid antibody and had a documented complement level. Significant higher mortality rates were found in the low complement group, with an odds ratio for mortality (OR 1.93 CI 1.63–2.27 p < .001). Deep vein thrombosis and pulmonary emboli rates were similar. Multivariate analysis confirmed that low complement was an independent predictor for mortality after controlling for age, sex, dyslipidemia, chronic heart failure (CHF), chronic kidney disease (CKD), and anemia.
Conclusions
Our study results indicate that low complement is associated with significantly higher mortality rates in admitted patients with elevated levels of anti-phospholipid antibodies. This finding correlates with recent literature suggesting a vital role for complement activation in anti-phospholipid syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Internal Medicine "T", Chaim Sheba Medical Center, Tel Hashomer, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel.
ORCID-Profile: Edward Itelman
Zitieren
APA
Itelman, E., Perelman, M., Bivar, N., Kent, D., Vaisman, A., Segal, G., Negru, L., & Dagan, A. (2023). Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study. Lupus. https://doi.org/10.1177/09612033231164091
Vancouver
Itelman E, Perelman M, Bivar N, Kent D, Vaisman A, Segal G, et al. Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study. Lupus. 2023. doi:10.1177/09612033231164091
BibTeX
@article{Itelman2023,
author = {Itelman, Edward and Perelman, Maxim and Bivar, Natali and Kent, Daniella and Vaisman, Adva and Segal, Gad and Negru, Liat and Dagan, Amir},
title = {Hospitalized patients with positive antiphospholipid antibodies who have low complement levels are at increased risk for death—a retrospective cohort study},
journal = {Lupus},
year = {2023},
doi = {10.1177/09612033231164091}
}
EUVIMED